Serum thymidine kinase 1 is a reliable maker for the assessment of the risk of developing malignancy: A case report
ZHIHENG CHEN et al, 2015, Oncology Letters CrossRef
A combined strategy of TK1, HE4 and CA125 shows better diagnostic performance than risk of ovarian malignancy algorithm (ROMA) in ovarian carcinoma
Cheng Zhu et al, 2022, Clinica Chimica Acta CrossRef
TK1 is an early screening marker for uterine corpus endometrial carcinoma and promotes its progression
Wenyao Liu et al, 2023, Gene Reports CrossRef
Methylation status of TK1 correlated with immune infiltrates in prostate cancer
Chenming Zhang et al, 2022, Frontiers in Genetics CrossRef
Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker
Jianjun Wang et al, 2017, Tumor Biology CrossRef
Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors
Yoonhee Kim et al, 2024, Journal of Veterinary Internal Medicine CrossRef
Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment
Tatsuya Ibe et al, 2019, BMJ Case Reports CrossRef
Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma
Corina Daniela Ene et al, 2020, Metabolites CrossRef
Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1
Steffen Rausch et al, 2015, Urologic Oncology: Seminars and Original Investigations CrossRef
Serum 8‐Oxo‐dG as a Predictor of Sensitivity and Outcome of Radiotherapy and Chemotherapy of Upper Gastrointestinal Tumours
Ali Pour Khavari et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis
Zhen-yu Song et al, 2019, Aging CrossRef
Pan-cancer analysis reveals that TK1 promotes tumor progression by mediating cell proliferation and Th2 cell polarization
Zhecheng Li et al, 2024, Cancer Cell International CrossRef
Increased levels of thymidine kinase 1 in malignant cell-derived extracellular vesicles
Ehsan Manouchehri Doulabi et al, 2024, Biochemistry and Biophysics Reports CrossRef
Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses
Chad R. Irwin et al, 2017, Frontiers in Oncology CrossRef
Diagnostic value of soluble interleukin-2 receptor in patients with lymphoproliferative diseases
N. K. Parilova et al, 2016, Onkologiya. Zhurnal imeni P.A.Gertsena CrossRef
Enzymes: Tumour Associated Biomarker
Farhadul Islam, 2023, Current Cancer Biomarkers CrossRef
A meta‑analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment
Li Dang et al, 2020, Molecular and Clinical Oncology CrossRef
The diagnostic value of serum microRNA-183 and TK1 as biomarkers for colorectal cancer diagnosis
Xiangrong Zhu et al, 2017, Open Life Sciences CrossRef
Clinical performance of a commercially available thymidine kinase 1 assay for diagnosis of lymphoma in 42 hospitalized horses (2017‐2020)
Caitlin Moore et al, 2021, Journal of Veterinary Internal Medicine CrossRef
Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer
FEIYU CHEN et al, 2013, Molecular and Clinical Oncology CrossRef
In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis
Orli Yogev et al, 2019, Cancer Research CrossRef
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
Yajing Zhu et al, 2024, Breast Cancer Research and Treatment CrossRef
Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion
Tian Tian et al, 2019, Journal of Clinical Laboratory Analysis CrossRef
The Half-Life of Serum Thymidine Kinase 1 Concentration Is an Important Tool for Monitoring Surgical Response in Patients with Lung Cancer: A Meta-Analysis
Xudan Lou et al, 2017, Genetic Testing and Molecular Biomarkers CrossRef
ELP3 Acetyltransferase is phosphorylated and regulated by the oncogenic anaplastic lymphoma kinase (ALK)
Meng-Tian Li et al, 2019, Biochemical Journal CrossRef
Thymidinkinase
S. Holdenrieder et al, 2019, Lexikon der Medizinischen Laboratoriumsdiagnostik CrossRef
STK1p As a Prognostic Biomarker for Overall Survival in non-small-cell Lung carcinoma, Based on real-world Data
Zhenxin Wang et al, 2021, Future Science OA CrossRef
Maternal high‐fat diet disrupted one‐carbon metabolism in offspring, contributing to nonalcoholic fatty liver disease
Hui Peng et al, 2021, Liver International CrossRef
Transcription factor Dp-1 knockdown downregulates thymidine kinase 1 expression to protect against proliferation and epithelial-mesenchymal transition in cervical cancer
Mei Wu et al, 2023, Functional & Integrative Genomics CrossRef
Serum thymidine kinase 1 is associated with Gleason score of patients with prostate carcinoma
Shujing Li et al, 2018, Oncology Letters CrossRef
Serological TK1 predict pre-cancer in routine health screenings of 56,178 people
Yu Wang et al, 2018, Cancer Biomarkers CrossRef
Dynamic changes in intron retention are tightly associated with regulation of splicing factors and proliferative activity during B-cell development
Sebastian Ullrich et al, 2020, Nucleic Acids Research CrossRef
Thymidine kinase 1 through the ages: a comprehensive review
Eliza E. Bitter et al, 2020, Cell & Bioscience CrossRef
Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker
Liya Wang et al, 2021, BMC Veterinary Research CrossRef
Standardized Centile Curves and Reference Intervals of Serum Thymidine Kinase 1 Levels in a Normal Chinese Population Using the LMS Method
Xia Cao et al, 2016, Genetic Testing and Molecular Biomarkers CrossRef
Decoding the temporal and regional specification of microglia in the developing human brain
Yanxin Li et al, 2022, Cell Stem Cell CrossRef
Thymidinkinase
S. Holdenrieder et al, 2018, Lexikon der Medizinischen Laboratoriumsdiagnostik CrossRef
Thymidine Kinase Type 1 and C‐Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer
K.A. Selting et al, 2016, Journal of Veterinary Internal Medicine CrossRef
Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy
Luc Cabel et al, 2020, Breast Cancer Research CrossRef
Dysregulation of mitotic machinery genes precedes genome instability during spontaneous pre-malignant transformation of mouse ovarian surface epithelial cells
Ulises Urzúa et al, 2016, BMC Genomics CrossRef
Serum Thymidine Kinase 1, Canine‐C‐Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune‐Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy
M. Grobman et al, 2017, Journal of Veterinary Internal Medicine CrossRef
Diagnosis and Staging of Equine Neoplasia
Imogen Johns et al, 2024, Veterinary Clinics of North America: Equine Practice CrossRef
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
Kiran Kumar Jagarlamudi et al, 2015, BMC Cancer CrossRef
The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study
Ondrej Fiala et al, 2015, Targeted Oncology CrossRef
Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people
Yu Wang et al, 2016, Cancer Biomarkers CrossRef
Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma
Liya Wang et al, 2021, BMC Molecular and Cell Biology CrossRef
Knockdown of Thymidine Kinase 1 Suppresses Cell Proliferation, Invasion, Migration, and Epithelial–Mesenchymal Transition in Thyroid Carcinoma Cells
Chang Liu et al, 2020, Frontiers in Oncology CrossRef
Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes
Zhiwu Wang et al, 2020, Bioscience Reports CrossRef
Immunohistochemistry for Thymidine Kinase-1 (TK1): A Potential Tool for the Prognostic Stratification of Breast Cancer Patients
Giuseppe Nicolò Fanelli et al, 2021, Journal of Clinical Medicine CrossRef
TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cells
Eliza E. Bitter et al, 2023, PLOS ONE CrossRef
A stable thymidine kinase 1 tetramer for improved quality control of serum level quantification
Xiangning Feng et al, 2025, Clinica Chimica Acta CrossRef
Serum Thymidine Kinase Activity: Analytical Performance, Age-Related Reference Ranges and Validation in Chronic Lymphocytic Leukemia
Eszter Szánthó et al, 2014, PLoS ONE CrossRef
The assay and clinical significance of serum thymidine kinase 1 in patients with colorectal carcinoma
Y. Zhang et al, 2015, European Surgery CrossRef
Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer
Ying-Ying Du et al, 2016, Chinese Medical Journal CrossRef
Selection of human single domain antibodies (sdAb) against thymidine kinase 1 and their incorporation into sdAb-Fc antibody constructs for potential use in cancer therapy
Edwin J. Velazquez et al, 2022, PLOS ONE CrossRef
Single-Cell Transcriptomics Identifies a Unique Entity and Signature Markers of Transit-Amplifying Cells in Human Corneal Limbus
Jin-Miao Li et al, 2021, Investigative Opthalmology & Visual Science CrossRef
Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study
Yi Jiang et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef